Your browser doesn't support javascript.
loading
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study.
Wu, Jianqiu; Song, Yongping; Su, Liping; Xu, Li; Chen, Tingchao; Zhao, Zhiyun; Zhang, Mingzhi; Li, Wei; Hu, Yu; Zhang, Xiaohong; Gao, Yuhuan; Niu, Zuoxing; Feng, Ru; Wang, Wei; Peng, Jiewen; Li, Xiaolin; Ouyang, Xuenong; Wu, Changping; Zhang, Weijing; Zeng, Yun; Xiao, Zhen; Liang, Yingmin; Zhuang, Yongzhi; Wang, Jishi; Sun, Zimin; Bai, Hai; Cui, Tongjian; Feng, Jifeng.
Affiliation
  • Wu J; Jiangsu Cancer Hospital, Nanjing, 210000, China.
  • Song Y; Henan Cancer Hospital, Zhengzhou, China.
  • Su L; Shanxi Cancer Hospital, Taiyuan, China.
  • Xu L; Shanghai Roche Pharmaceuticals Ltd, Shanghai, China.
  • Chen T; Shanghai Roche Pharmaceuticals Ltd, Shanghai, China.
  • Zhao Z; Shanghai Roche Pharmaceuticals Ltd, Shanghai, China.
  • Zhang M; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Li W; Jilin University First Affiliated Hospital, Changchun, China.
  • Hu Y; Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China.
  • Zhang X; The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Gao Y; Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Niu Z; Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan, China.
  • Feng R; Nanfang Medical University Nanfang Hospital, Guangzhou, China.
  • Wang W; Guangdong Foshan First Hospital, Foshan, China.
  • Peng J; Guangdong Zhongshan People's Hospital, Zhongshan, China.
  • Li X; Xiangya Hospital Central South University, Changsha, China.
  • Ouyang X; Fuzhou General Hospital of Nanjing Military Command, Fuzhou, China.
  • Wu C; Changzhou First People's Hospital, Changzhou, China.
  • Zhang W; 307 Hospital of PLA, Beijing, China.
  • Zeng Y; First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Xiao Z; Affiliated hospital of Neimenggu Medical College, Huhehaote, China.
  • Liang Y; The Fourth Military Medical University Affiliated Tangdu Hospital, Xi'an, China.
  • Zhuang Y; Daqing General Hospital Group Oilfield General Hospital, Daqing, China.
  • Wang J; Affiliated Hospital of Guiyang Medical College, Guiyang, China.
  • Sun Z; Anhui Provincial Hospital, Hefei, China.
  • Bai H; Lanzhou Military Hospital, Lanzhou, China.
  • Cui T; Fujian provincial hospital, Fuzhou, China.
  • Feng J; Jiangsu Cancer Hospital, Nanjing, 210000, China. fjif@medmail.com.cn.
BMC Cancer ; 16: 537, 2016 07 26.
Article in En | MEDLINE | ID: mdl-27460571
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Pragmatic Clinical Trials as Topic / Rituximab Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2016 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Pragmatic Clinical Trials as Topic / Rituximab Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2016 Type: Article Affiliation country: China